Jagsonpal Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Jagsonpal Pharma	Fredun Pharma	Syncom Formulations
Operational Metrics
Financials
5 yr Average ROE	16.01 %	11.84 %	9.79 %
5yr average Equity Multiplier	1.27	2.85	1.41
5yr Average Asset Turnover Ratio	1.09	1.08	0.81
5yr Avg Net Profit Margin	12.08 %	3.9 %	8.78 %
Price to Book	4.78	4.75	3.35
P/E	30.62	40.5	18.28
5yr Avg Cash Conversion Cycle	2.39 Days	175.29 Days	61.57 Days
Inventory Days	31.56 Days	146.68 Days	27.32 Days
Days Receivable	15.63 Days	142.46 Days	82.75 Days
Days Payable	59.94 Days	112.95 Days	79.41 Days
5yr Average Interest Coverage Ratio	66.99	2.62	31.44
5yr Avg ROCE	18.99 %	22.71 %	13.63 %
5yr Avg Operating Profit Margin	13.23 %	9.7 %	9.97 %
5 yr average Debt to Equity	0.01	0.93	0.19
5yr CAGR Net Profit	26.54 %	25.5 %	36.24 %
5yr Average Return on Assets	12.71 %	4.18 %	7.11 %
Shareholdings
Promoter Holding	67.89 %	44.17 %	50.57 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.82 %	-5.98 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Jagsonpal Pharma	Fredun Pharma	Syncom Formulations
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 0 Renting of Property 0 Trading of Commodities 0 Pharmaceutical Drugs & Formulations 0	Product Wise Break-Up Renting of Property 0 Pharmaceutical Drugs & Formulations 0 Trading of Commodities 0 Pharmaceutical 100.0 Pharmaceuticals 0	Product Wise Break-Up Rental Income 0.73 Pharmaceutical 99.26 Commodity 0.01 0 Pharmaceuticals 0
Location Wise Break-Up	Location Wise Break-Up India 98.7 Rest of the World 0 India 0 International 0 Others 1.3	Location Wise Break-Up India 83.13 International 0 Rest of the World 16.86 Others 0.01	Location Wise Break-Up India 0 International 84.5 Rest of the World 0 Others 15.5